Back to Search
MARYAM BANIKAZEMI, MD
MD
Ph.D. Medical Genetics
NPI: 1831164672Individual
Specialties, Licenses & Credentials
Research & Publications (17)
Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?
PMID 16932395·Nat Clin Pract Nephrol·2006
8-other
Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.
PMID 15939645·Mol Genet Metab·2005
8-other
Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.
PMID 19150871·Stroke·2009
8-other
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.
PMID 19218538·Nephrol Dial Transplant·2009
8-other
Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.
PMID 18596579·Pediatr Res·2008
8-other
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.
PMID 18037317·Mol Genet Metab·2008
8-other
Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.
PMID 17347915·J Inherit Metab Dis·2007
8-other
Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.
PMID 17409312·J Am Soc Nephrol·2007
3-trial
Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.
PMID 17179052·Ann Intern Med·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 WOODS RD
VALHALLA, NY 10595 - Phone
- (914) 909-9018
Quick Facts
- NPI
- 1831164672
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 17
Are you this provider?
Claim Your Profile